SR2595

Code: SML2037-25MG D2-231

Biochem/physiol Actions

SR2595 is an inverse agonist of PPARG (PPARγ) with an IC50 value of 30 nM. It was found to promote osteogenic differentiation of isolated bone ma...


read more

Your Price
£515.00 25MG
£618.00 inc. VAT

Biochem/physiol Actions

SR2595 is an inverse agonist of PPARG (PPARγ) with an IC50 value of 30 nM. It was found to promote osteogenic differentiation of isolated bone marrow-derived mesenchymal stem cells accompanied by increased expression of bone morphogenetic proteins BMP2 and BMP6. SR2595 showed good pharmacokinetics and can be administered orally. It caused no significant change in insulin sensitivity, fasting insulin levels, food consumption or body weight when administered orally to mice.

assay≥98% (HPLC)
colorwhite to faint brown
formpowder
shipped inwet ice
SMILES stringO=C(C(C=C1)=CC2=C1N(C(C)=C2C)CC(C=C3)=CC=C3C4=C(C(O)=O)C=CC=C4)N[C@H](C(C=C5)=CC=C5C(C)(C)C)C
solubilityDMSO: 2 mg/mL, clear
storage temp.−20°C
Code
Description
Unit Size
List Price
Qty
SML2037-5MG
Unit:5MG
List Price: £174.00
Source:List Price
ADD
This product has met the following criteria to qualify for the following awards: